Table 4: Different stages of CKD per eGFR calculated by EPI formula at the start of study.
CKD Stage |
No |
Yes |
Combined |
||
Treatment |
Treatment |
p-value |
|||
1 |
N |
3466 |
13624 |
17090 |
|
% Group |
35.53 |
35.2 |
35.27 |
||
2 |
N |
4914 |
19602 |
24517 |
|
% Group |
50.38 |
50.64 |
50.59 |
||
3 |
N |
1291 |
5145 |
6435 |
|
% Group |
13.23 |
13.29 |
13.28 |
||
4 |
N |
67 |
268 |
335 |
|
% Group |
0.69 |
0.69 |
0.69 |
||
5 |
N |
17 |
67 |
84 |
|
% Group |
0.17 |
0.17 |
0.17 |
||
Total |
N |
9755 |
38706 |
48461 |
0.9846 |
% Group |
20.13 |
79.87 |
100 |
Note: ANOVA p-value overall, 0.9846 (no post-hoc comparisons per separate stages). Differences between treatment groups for stages were compared using ANOVA. No post-hoc comparisons per separate stages.
Abbreviations: CKD: Chronic kidney disease; N: Number.